A detailed history of Mv Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mv Capital Management, Inc. holds 2,699 shares of BMY stock, worth $156,542. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,699
Previous 2,930 7.88%
Holding current value
$156,542
Previous $121,000 14.88%
% of portfolio
0.02%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $9,161 - $11,954
-231 Reduced 7.88%
2,699 $139,000
Q2 2024

Aug 01, 2024

BUY
$40.25 - $52.99 $37,875 - $49,863
941 Added 47.31%
2,930 $121,000
Q1 2024

Apr 18, 2024

SELL
$47.98 - $54.4 $20,391 - $23,120
-425 Reduced 17.61%
1,989 $107,000
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $3,732 - $4,454
77 Added 3.29%
2,414 $123,000
Q3 2023

Nov 07, 2023

BUY
$57.89 - $64.73 $10,651 - $11,910
184 Added 8.55%
2,337 $135,000
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $12,168 - $13,511
191 Added 9.73%
2,153 $137,000
Q1 2023

Apr 26, 2023

BUY
$65.71 - $74.53 $3,351 - $3,801
51 Added 2.67%
1,962 $135,000
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $8,217 - $9,730
120 Added 6.7%
1,911 $0
Q3 2022

Oct 24, 2022

BUY
$0.13 - $76.84 $43 - $25,818
336 Added 23.09%
1,791 $127,000
Q2 2022

Jul 19, 2022

BUY
$72.62 - $79.98 $4,647 - $5,118
64 Added 4.6%
1,455 $112,000
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $8,299 - $9,952
135 Added 10.75%
1,391 $102,000
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $2,091 - $2,438
39 Added 3.2%
1,256 $78,000
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $5,680 - $6,653
96 Added 8.56%
1,217 $72,000
Q2 2021

Aug 03, 2021

BUY
$61.91 - $67.42 $43,275 - $47,126
699 Added 165.64%
1,121 $75,000
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $71,445 - $80,354
-1,204 Reduced 74.05%
422 $27,000
Q1 2020

Apr 28, 2020

BUY
$46.4 - $67.43 $1,763 - $2,562
38 Added 2.39%
1,626 $91,000
Q4 2019

Feb 05, 2020

SELL
$49.21 - $64.19 $2,804 - $3,658
-57 Reduced 3.47%
1,588 $102,000
Q3 2019

Nov 21, 2019

BUY
$42.77 - $50.71 $58,979 - $69,929
1,379 Added 518.42%
1,645 $83,000
Q1 2019

May 02, 2019

SELL
$45.12 - $53.8 $2,887 - $3,443
-64 Reduced 19.39%
266 $13,000
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $36,570 - $47,422
-750 Reduced 69.44%
330 $17,000
Q1 2018

May 09, 2018

BUY
$59.92 - $68.98 $44,940 - $51,735
750 Added 227.27%
1,080 $68,000
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $18,225 - $21,034
330
330 $21,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.